C92.1 - Chronic myeloid leukemia, BCR/ABL-positive

  • Applicable to Chronic myeloid leukemia, BCR/ABL-positive
  • The 2025 edition of ICD10-CM C92.1 became effective on October 1, 2024.
  • This is the American ICD10-CM version of C92.1 - other international versions of ICD10 C92.1 may differ.
  • C92.1 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • C92.1 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
  • C92.1 - Chronic myeloid leukemia, BCR/ABL-positive
    • C92.1 - Chronic myeloid leukemia, BCR/ABL-positive
    • C92.10 - Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
    • C92.11 - Chronic myeloid leukemia, BCR/ABL-positive, in remission
    • C92.12 - Chronic myeloid leukemia, BCR/ABL-positive, in relapse

 Inclusion Term

  • Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive
  • Chronic myelogenous leukemia, t(9;22) (q34;q11)
  • Chronic myelogenous leukemia with crisis of blast cells

Type 1 Excludes

  • atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
  • chronic myelomonocytic leukemia (C93.1-)
  • chronic myeloproliferative disease (D47.1)

The following codes above C92.1 contain annotation back-references that may be applicable to C92.1:

Chapter: C00-D49 Neoplasms

Section: C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue

Category: C92 Myeloid leukemia

  
Non-Billable/Non-Specific Code

Browse other similar CM codes

                              

Please, give attribution to our website icd-10code.com